• 2022 Recap &

    2023 Roadmap

    Here's a brief summary of major highlights from 2022 and a few glimpses at what to expect from 2023 (best taken with a pinch of salt!).

     

    A big thank you to our partners, investors, advisors and well-wishers from around the world!

  • 2022

    Our best year since the pandemic!

    Doing Well by Doing Good

    We grew revenues by nearly 300% YoY in 2022. This brings the total scan sales worldwide to over 2 million. That’s two million women who will receive access to life saving breast exams across 12 countries - many of them for the first time!

    We’re Growing with Awesome, Global and Diverse Talent!

    Join us in Welcoming:

    Shikha Jaisinghani, Executive Director Smita Asrani, VP People Operations
    Dr. Angela Honegger, VP Innovation

    Luis Sagarzazu, Regional Manager LatAm Dr. Hossam Abou El Enein – Regional Manager Middle East & North Africa

    Memorial Sloan Kettering Cancer Center expands iBreastExam Research

    2022 Global Women’s HealthTech Award from The World Bank, IFC, CTA

    The award was announced during the CES (Consumer Electronics Show) keynote address in Vegas! 

    We announced the US launch of iBreastExam under a definitive, three-year Distribution Agreement. Here’s a link to iBreastExam webpage on Siemens Healthineers’ website.

    iBreastExam at Fortune Brainstorm Health Conference Main Stage

    Amidst global thought leaders, change makers and CEOs of some of the biggest companies, iBreastExam Featured at the Fortune Brainstorm Health, from the Main Stage in Los Angeles.

    The Union for InternationalCancer Control is the world’s leading cancer care community. UICC Invited UE LifeSciences to present at the World Cancer Congress in Geneva, Switzerland.

    We're a member of the American Cancer Society!

    We became a member of the American Cancer Society and joined the Cancer Action Network. 

    Goa Project reaches 50,000 women

    In collaboration with Goa Ministry of Health and YouWeCan Foundation, over 50,000 women have received life saving breast examinations in Goa.

  • 2023

    Expected to be (even) better than 2022! (🤞)

     

    We are super stoked about our prospects for 2023. We are fully prepared to grow from
    the capabilities and infrastructure point of view with an excellent team, a
    robust product suite and a growing set of partnerships globally for product
    development, marketing, sales and distribution.

    UE LifeSciences has already secured purchase orders for 2023 in the amount equal to the entire year’s revenue for 2022!

     

    In 2023, we hope to grow revenues by a factor of 5x YoY with EBITDA >40%!

     

  • Going Global.

    Doing Good.

    At Scale.

    We are planning and entering in to several new partnerships across Latin America, Oceania, Middle East and North Africa Region, Southeast Asia and China.

     

    We are enhancing our engagements with world leading Pharma & MedTech Partners with potential collaborations in a number of geographies.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More